MedHub-AI and Terumo Partner to Introduce AI-Based FFR in Japan
MedHub-AI has announced a distribution agreement with Terumo Corporation to bring its AI-powered AutocathFFR software to the Japanese market, announced in a press release. This collaboration aims to revolutionize coronary physiology assessment by offering a non-invasive, AI-driven alternative to traditional Fractional Flow Reserve (FFR) techniques.
AutocathFFR utilizes advanced AI algorithms to calculate precise FFR values directly from routine X-ray coronary angiograms, eliminating the need for invasive guidewires or drug-induced vessel dilation. This innovation provides fast, consistent results in just 37 seconds, enhancing workflow reliability and minimizing operator variability.
The partnership with Terumo will expand the product lineup in the cardiovascular field, offering healthcare professionals a wider range of options and contributing to improved patient outcomes. MedHub-AI is also progressing through the final stages of its regulatory pathway and anticipates receiving FDA approval soon, paving the way for broader clinical adoption and global market expansion.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 31 AI Agent Controls Brain Injection in Live Mouse After Claude Opus Refuses Oct 31 Patient Sues Allegheny Health Network and Highmark Over Abridge AI Recordings Oct 31 OpenAI Releases GPT-Rosalind-6 for Approved Biology Researchers Oct 30 Surveys Find Widespread AI Chatbot Use Among Teens and Tweens Oct 30 Widow Sues OpenAI and Luka Over Husband's SuicideLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
AIRS Medical Gets FDA Clearance for MRI Body Composition Tool
Tairex Launches Multi Agent System for Clinical Collaboration
Azra AI Acquires Blackford Analysis
AstraZeneca and Oracle Partner on AI for Clinical Trials
Tufts Medicine Uses Humata Health to Automate Prior Authorization
Daily AI Brief: the AI news that matters, in your inbox.